日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models.

阻断 LIF 和 PD-L1 可增强 SBRT 在小鼠 PDAC 模型中的抗肿瘤疗效

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010820
Ye Jian, Qin Shuyang S, Hughson Angela L, Hannon Gary, Salama Noah A, Vrooman Tara G, Lesch Maggie L, Lesser Sidney, Eckl Sarah L, Jewell Rachel, Benoodt Lauren, Mills Bradley N, Johnston Carl J, Lord Edith, Belt Brian A, Calvi Laura M, Linehan David, Luheshi Nadia, Eyles Jim, Gerber Scott A
肿瘤
发表日期：2025
文献求助 收藏

Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models

阻断 LIF 和 PD-L1 可增强临床前 PDAC 模型中的化疗效果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17020204
Ye, Jian; Qin, Shuyang S; Hughson, Angela L; Hannon, Gary; Vrooman, Tara G; Lesch, Maggie L; Eckl, Sarah L; Benoodt, Lauren; Mills, Bradley N; Lord, Edith M; Belt, Brian A; Linehan, David C; Luheshi, Nadia; Eyles, Jim; Gerber, Scott A
PD-L1
LIF
发表日期：2025
文献求助 收藏

Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer.

将 IL-12 mRNA 纳米技术与 SBRT 相结合，可消除胰腺癌临床前模型中的 T 细胞耗竭

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2024.102350
Hughson Angela L, Hannon Gary, Salama Noah A, Vrooman Tara G, Stockwell Caroline A, Mills Bradley N, Garrett-Larsen Jesse, Qiu Haoming, Katerji Roula, Benoodt Lauren, Johnston Carl J, Murphy Joseph D, Kruger Emma, Ye Jian, Gavras Nicholas W, Keeley David C, Qin Shuyang S, Lesch Maggie L, Muhitch Jason B, Love Tanzy M T, Calvi Laura M, Lord Edith M, Luheshi Nadia, Elyes Jim, Linehan David C, Gerber Scott A
细胞生物学
胰腺癌
发表日期：2024
文献求助 收藏